nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Uveitis—Vemurafenib—skin cancer	0.0786	0.0786	CcSEcCtD
Metipranolol—Lacrimation—Fluorouracil—skin cancer	0.022	0.022	CcSEcCtD
Metipranolol—Atrial fibrillation—Vemurafenib—skin cancer	0.021	0.021	CcSEcCtD
Metipranolol—Blepharitis—Fluorouracil—skin cancer	0.021	0.021	CcSEcCtD
Metipranolol—Arthritis—Vemurafenib—skin cancer	0.0205	0.0205	CcSEcCtD
Metipranolol—Atrial fibrillation—Imiquimod—skin cancer	0.0179	0.0179	CcSEcCtD
Metipranolol—Arthritis—Imiquimod—skin cancer	0.0175	0.0175	CcSEcCtD
Metipranolol—Myalgia—Vismodegib—skin cancer	0.0165	0.0165	CcSEcCtD
Metipranolol—Lacrimation—Docetaxel—skin cancer	0.0159	0.0159	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Vismodegib—skin cancer	0.0144	0.0144	CcSEcCtD
Metipranolol—Bronchitis—Imiquimod—skin cancer	0.0141	0.0141	CcSEcCtD
Metipranolol—Lacrimation increased—Fluorouracil—skin cancer	0.014	0.014	CcSEcCtD
Metipranolol—Acute coronary syndrome—Imiquimod—skin cancer	0.0129	0.0129	CcSEcCtD
Metipranolol—Myocardial infarction—Imiquimod—skin cancer	0.0128	0.0128	CcSEcCtD
Metipranolol—Conjunctivitis—Imiquimod—skin cancer	0.0127	0.0127	CcSEcCtD
Metipranolol—Arthritis—Bleomycin—skin cancer	0.0124	0.0124	CcSEcCtD
Metipranolol—Abnormal vision—Temozolomide—skin cancer	0.0122	0.0122	CcSEcCtD
Metipranolol—Photophobia—Fluorouracil—skin cancer	0.0121	0.0121	CcSEcCtD
Metipranolol—Rhinitis—Imiquimod—skin cancer	0.0118	0.0118	CcSEcCtD
Metipranolol—Asthenia—Vismodegib—skin cancer	0.0114	0.0114	CcSEcCtD
Metipranolol—Visual impairment—Imiquimod—skin cancer	0.0113	0.0113	CcSEcCtD
Metipranolol—Cough—Vemurafenib—skin cancer	0.0105	0.0105	CcSEcCtD
Metipranolol—Myalgia—Vemurafenib—skin cancer	0.0102	0.0102	CcSEcCtD
Metipranolol—Lacrimation increased—Docetaxel—skin cancer	0.0101	0.0101	CcSEcCtD
Metipranolol—Rash—Vismodegib—skin cancer	0.00999	0.00999	CcSEcCtD
Metipranolol—Dermatitis—Vismodegib—skin cancer	0.00999	0.00999	CcSEcCtD
Metipranolol—Nausea—Vismodegib—skin cancer	0.00942	0.00942	CcSEcCtD
Metipranolol—Acute coronary syndrome—Bleomycin—skin cancer	0.00917	0.00917	CcSEcCtD
Metipranolol—Myocardial infarction—Bleomycin—skin cancer	0.00912	0.00912	CcSEcCtD
Metipranolol—Palpitations—Imiquimod—skin cancer	0.00904	0.00904	CcSEcCtD
Metipranolol—Cough—Imiquimod—skin cancer	0.00893	0.00893	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00892	0.00892	CcSEcCtD
Metipranolol—Hypertension—Imiquimod—skin cancer	0.00884	0.00884	CcSEcCtD
Metipranolol—Myalgia—Imiquimod—skin cancer	0.00871	0.00871	CcSEcCtD
Metipranolol—Anxiety—Imiquimod—skin cancer	0.00868	0.00868	CcSEcCtD
Metipranolol—Discomfort—Imiquimod—skin cancer	0.00861	0.00861	CcSEcCtD
Metipranolol—Bronchitis—Temozolomide—skin cancer	0.00846	0.00846	CcSEcCtD
Metipranolol—Oedema—Imiquimod—skin cancer	0.00835	0.00835	CcSEcCtD
Metipranolol—Angina pectoris—Fluorouracil—skin cancer	0.0079	0.0079	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00761	0.00761	CcSEcCtD
Metipranolol—Dyspnoea—Imiquimod—skin cancer	0.00745	0.00745	CcSEcCtD
Metipranolol—Somnolence—Imiquimod—skin cancer	0.00742	0.00742	CcSEcCtD
Metipranolol—Hypersensitivity—Vemurafenib—skin cancer	0.00722	0.00722	CcSEcCtD
Metipranolol—Atrial fibrillation—Docetaxel—skin cancer	0.00715	0.00715	CcSEcCtD
Metipranolol—Acute coronary syndrome—Fluorouracil—skin cancer	0.00713	0.00713	CcSEcCtD
Metipranolol—Myocardial infarction—Fluorouracil—skin cancer	0.00709	0.00709	CcSEcCtD
Metipranolol—Conjunctivitis—Fluorouracil—skin cancer	0.00703	0.00703	CcSEcCtD
Metipranolol—Asthenia—Vemurafenib—skin cancer	0.00703	0.00703	CcSEcCtD
Metipranolol—Epistaxis—Fluorouracil—skin cancer	0.00682	0.00682	CcSEcCtD
Metipranolol—Visual impairment—Temozolomide—skin cancer	0.00679	0.00679	CcSEcCtD
Metipranolol—Rhinitis—Fluorouracil—skin cancer	0.00651	0.00651	CcSEcCtD
Metipranolol—Dizziness—Vemurafenib—skin cancer	0.00648	0.00648	CcSEcCtD
Metipranolol—Cough—Bleomycin—skin cancer	0.00634	0.00634	CcSEcCtD
Metipranolol—Myalgia—Bleomycin—skin cancer	0.00619	0.00619	CcSEcCtD
Metipranolol—Rash—Vemurafenib—skin cancer	0.00617	0.00617	CcSEcCtD
Metipranolol—Dermatitis—Vemurafenib—skin cancer	0.00617	0.00617	CcSEcCtD
Metipranolol—Hypersensitivity—Imiquimod—skin cancer	0.00615	0.00615	CcSEcCtD
Metipranolol—Headache—Vemurafenib—skin cancer	0.00614	0.00614	CcSEcCtD
Metipranolol—Discomfort—Bleomycin—skin cancer	0.00612	0.00612	CcSEcCtD
Metipranolol—Asthenia—Imiquimod—skin cancer	0.00599	0.00599	CcSEcCtD
Metipranolol—Oedema—Bleomycin—skin cancer	0.00593	0.00593	CcSEcCtD
Metipranolol—Nausea—Vemurafenib—skin cancer	0.00582	0.00582	CcSEcCtD
Metipranolol—Vision blurred—Temozolomide—skin cancer	0.00578	0.00578	CcSEcCtD
Metipranolol—Myalgia—Dactinomycin—skin cancer	0.00577	0.00577	CcSEcCtD
Metipranolol—Discomfort—Dactinomycin—skin cancer	0.0057	0.0057	CcSEcCtD
Metipranolol—Angina pectoris—Docetaxel—skin cancer	0.0057	0.0057	CcSEcCtD
Metipranolol—Oedema—Dactinomycin—skin cancer	0.00553	0.00553	CcSEcCtD
Metipranolol—Dizziness—Imiquimod—skin cancer	0.00552	0.00552	CcSEcCtD
Metipranolol—Palpitations—Temozolomide—skin cancer	0.00542	0.00542	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00541	0.00541	CcSEcCtD
Metipranolol—Cough—Temozolomide—skin cancer	0.00535	0.00535	CcSEcCtD
Metipranolol—Vision blurred—Fluorouracil—skin cancer	0.00533	0.00533	CcSEcCtD
Metipranolol—Hypertension—Temozolomide—skin cancer	0.00529	0.00529	CcSEcCtD
Metipranolol—Dyspnoea—Bleomycin—skin cancer	0.00529	0.00529	CcSEcCtD
Metipranolol—Rash—Imiquimod—skin cancer	0.00527	0.00527	CcSEcCtD
Metipranolol—Dermatitis—Imiquimod—skin cancer	0.00526	0.00526	CcSEcCtD
Metipranolol—Headache—Imiquimod—skin cancer	0.00523	0.00523	CcSEcCtD
Metipranolol—Myalgia—Temozolomide—skin cancer	0.00522	0.00522	CcSEcCtD
Metipranolol—Anxiety—Temozolomide—skin cancer	0.0052	0.0052	CcSEcCtD
Metipranolol—Discomfort—Temozolomide—skin cancer	0.00516	0.00516	CcSEcCtD
Metipranolol—Acute coronary syndrome—Docetaxel—skin cancer	0.00514	0.00514	CcSEcCtD
Metipranolol—Myocardial infarction—Docetaxel—skin cancer	0.00512	0.00512	CcSEcCtD
Metipranolol—Conjunctivitis—Docetaxel—skin cancer	0.00507	0.00507	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00504	0.00504	CcSEcCtD
Metipranolol—Oedema—Temozolomide—skin cancer	0.00501	0.00501	CcSEcCtD
Metipranolol—Nausea—Imiquimod—skin cancer	0.00496	0.00496	CcSEcCtD
Metipranolol—Epistaxis—Docetaxel—skin cancer	0.00492	0.00492	CcSEcCtD
Metipranolol—Myalgia—Fluorouracil—skin cancer	0.00481	0.00481	CcSEcCtD
Metipranolol—Discomfort—Fluorouracil—skin cancer	0.00475	0.00475	CcSEcCtD
Metipranolol—Rhinitis—Docetaxel—skin cancer	0.0047	0.0047	CcSEcCtD
Metipranolol—Oedema—Fluorouracil—skin cancer	0.00461	0.00461	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00456	0.00456	CcSEcCtD
Metipranolol—Visual impairment—Docetaxel—skin cancer	0.00451	0.00451	CcSEcCtD
Metipranolol—Dyspnoea—Temozolomide—skin cancer	0.00446	0.00446	CcSEcCtD
Metipranolol—Somnolence—Temozolomide—skin cancer	0.00445	0.00445	CcSEcCtD
Metipranolol—Hypersensitivity—Bleomycin—skin cancer	0.00437	0.00437	CcSEcCtD
Metipranolol—Asthenia—Bleomycin—skin cancer	0.00426	0.00426	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.0042	0.0042	CcSEcCtD
Metipranolol—Dyspnoea—Fluorouracil—skin cancer	0.00411	0.00411	CcSEcCtD
Metipranolol—Somnolence—Fluorouracil—skin cancer	0.0041	0.0041	CcSEcCtD
Metipranolol—Hypersensitivity—Dactinomycin—skin cancer	0.00408	0.00408	CcSEcCtD
Metipranolol—Asthenia—Dactinomycin—skin cancer	0.00397	0.00397	CcSEcCtD
Metipranolol—Rash—Bleomycin—skin cancer	0.00374	0.00374	CcSEcCtD
Metipranolol—Dermatitis—Bleomycin—skin cancer	0.00374	0.00374	CcSEcCtD
Metipranolol—Hypersensitivity—Temozolomide—skin cancer	0.00369	0.00369	CcSEcCtD
Metipranolol—Palpitations—Docetaxel—skin cancer	0.0036	0.0036	CcSEcCtD
Metipranolol—Asthenia—Temozolomide—skin cancer	0.00359	0.00359	CcSEcCtD
Metipranolol—Cough—Docetaxel—skin cancer	0.00356	0.00356	CcSEcCtD
Metipranolol—Nausea—Bleomycin—skin cancer	0.00352	0.00352	CcSEcCtD
Metipranolol—Hypertension—Docetaxel—skin cancer	0.00352	0.00352	CcSEcCtD
Metipranolol—Rash—Dactinomycin—skin cancer	0.00349	0.00349	CcSEcCtD
Metipranolol—Myalgia—Docetaxel—skin cancer	0.00347	0.00347	CcSEcCtD
Metipranolol—Hypersensitivity—Fluorouracil—skin cancer	0.0034	0.0034	CcSEcCtD
Metipranolol—Oedema—Docetaxel—skin cancer	0.00333	0.00333	CcSEcCtD
Metipranolol—Dizziness—Temozolomide—skin cancer	0.00331	0.00331	CcSEcCtD
Metipranolol—Nausea—Dactinomycin—skin cancer	0.00329	0.00329	CcSEcCtD
Metipranolol—Rash—Temozolomide—skin cancer	0.00316	0.00316	CcSEcCtD
Metipranolol—Dermatitis—Temozolomide—skin cancer	0.00315	0.00315	CcSEcCtD
Metipranolol—Headache—Temozolomide—skin cancer	0.00314	0.00314	CcSEcCtD
Metipranolol—Dizziness—Fluorouracil—skin cancer	0.00305	0.00305	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00303	0.00303	CcSEcCtD
Metipranolol—Nausea—Temozolomide—skin cancer	0.00297	0.00297	CcSEcCtD
Metipranolol—Dyspnoea—Docetaxel—skin cancer	0.00297	0.00297	CcSEcCtD
Metipranolol—Somnolence—Docetaxel—skin cancer	0.00296	0.00296	CcSEcCtD
Metipranolol—Rash—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Metipranolol—Dermatitis—Fluorouracil—skin cancer	0.0029	0.0029	CcSEcCtD
Metipranolol—Headache—Fluorouracil—skin cancer	0.00289	0.00289	CcSEcCtD
Metipranolol—Nausea—Fluorouracil—skin cancer	0.00274	0.00274	CcSEcCtD
Metipranolol—Hypersensitivity—Docetaxel—skin cancer	0.00245	0.00245	CcSEcCtD
Metipranolol—Asthenia—Docetaxel—skin cancer	0.00239	0.00239	CcSEcCtD
Metipranolol—Dizziness—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Metipranolol—Rash—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Metipranolol—Dermatitis—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Metipranolol—Headache—Docetaxel—skin cancer	0.00209	0.00209	CcSEcCtD
Metipranolol—Nausea—Docetaxel—skin cancer	0.00198	0.00198	CcSEcCtD
